PATENT CLAIM ANALYSIS

Application Number: 15870659
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "462000"]

Abstract:
Methods for increasing specificity of RNA-guided genome editing, e.g., editing using CRISPR/Cas9 systems.

Claim (Index 9):
The composition of  claim 7 , wherein the one or more deoxyribonucleotides comprise thymine in place of uracil.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.14286
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775930', '14213723', '15415431', '15430218', '14213479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7739190080691047
- 35 USC 102 Novelty (BERT): 0.5974847196168772
- Combined Prediction Score: 0.756275579223882
- Mean Citation Score: 692.2233120000003
- Max Citation Score: 731.4343
- Similarity Product: 386.8866186027705

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test